Treatment of Neurodevelopmental disorders in Adulthood

Eero Castrén, Ype Elgersma, Lamberto Maffei, Randi J Hagerman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Brain development in neurodevelopmental disorders has been considered to comprise a sequence of critical periods, and abnormalities occurring during early development have been considered irreversible in adulthood. However, findings in mouse models of neurodevelopmental disorders, including fragile X, Rett syndrome, Down syndrome, and neurofibromatosis type I suggest that it is possible to reverse certain molecular, electrophysiological, and behavioral deficits associated with these disorders in adults by genetic or pharmacological manipulations. Furthermore, recent studies have suggested that critical period-like plasticity can be reactivated in the adult brain by environmental manipulations or by pharmacotherapy. These studies open up a tantalizing possibility that targeted pharmacological treatments in combination with regimes of training or rehabilitation might alleviate or reverse the symptoms of neurodevelopmental disorders even after the end of critical developmental periods. Even though translation from animal experimentation to clinical practice is challenging, these results suggest a rational basis for treatment of neurodevelopmental disorders in adulthood.

Original languageEnglish (US)
Pages (from-to)14074-14079
Number of pages6
JournalJournal of Neuroscience
Volume32
Issue number41
DOIs
StatePublished - Oct 10 2012

Fingerprint

Pharmacology
Rett Syndrome
Fragile X Syndrome
Neurofibromatosis 1
Brain
Therapeutics
Down Syndrome
Rehabilitation
Drug Therapy
Neurodevelopmental Disorders
Critical Period (Psychology)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Treatment of Neurodevelopmental disorders in Adulthood. / Castrén, Eero; Elgersma, Ype; Maffei, Lamberto; Hagerman, Randi J.

In: Journal of Neuroscience, Vol. 32, No. 41, 10.10.2012, p. 14074-14079.

Research output: Contribution to journalArticle

Castrén, Eero ; Elgersma, Ype ; Maffei, Lamberto ; Hagerman, Randi J. / Treatment of Neurodevelopmental disorders in Adulthood. In: Journal of Neuroscience. 2012 ; Vol. 32, No. 41. pp. 14074-14079.
@article{014e0b9fad5e4d4aa8c1e2fbd7506a7f,
title = "Treatment of Neurodevelopmental disorders in Adulthood",
abstract = "Brain development in neurodevelopmental disorders has been considered to comprise a sequence of critical periods, and abnormalities occurring during early development have been considered irreversible in adulthood. However, findings in mouse models of neurodevelopmental disorders, including fragile X, Rett syndrome, Down syndrome, and neurofibromatosis type I suggest that it is possible to reverse certain molecular, electrophysiological, and behavioral deficits associated with these disorders in adults by genetic or pharmacological manipulations. Furthermore, recent studies have suggested that critical period-like plasticity can be reactivated in the adult brain by environmental manipulations or by pharmacotherapy. These studies open up a tantalizing possibility that targeted pharmacological treatments in combination with regimes of training or rehabilitation might alleviate or reverse the symptoms of neurodevelopmental disorders even after the end of critical developmental periods. Even though translation from animal experimentation to clinical practice is challenging, these results suggest a rational basis for treatment of neurodevelopmental disorders in adulthood.",
author = "Eero Castr{\'e}n and Ype Elgersma and Lamberto Maffei and Hagerman, {Randi J}",
year = "2012",
month = "10",
day = "10",
doi = "10.1523/JNEUROSCI.3287-12.2012",
language = "English (US)",
volume = "32",
pages = "14074--14079",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "41",

}

TY - JOUR

T1 - Treatment of Neurodevelopmental disorders in Adulthood

AU - Castrén, Eero

AU - Elgersma, Ype

AU - Maffei, Lamberto

AU - Hagerman, Randi J

PY - 2012/10/10

Y1 - 2012/10/10

N2 - Brain development in neurodevelopmental disorders has been considered to comprise a sequence of critical periods, and abnormalities occurring during early development have been considered irreversible in adulthood. However, findings in mouse models of neurodevelopmental disorders, including fragile X, Rett syndrome, Down syndrome, and neurofibromatosis type I suggest that it is possible to reverse certain molecular, electrophysiological, and behavioral deficits associated with these disorders in adults by genetic or pharmacological manipulations. Furthermore, recent studies have suggested that critical period-like plasticity can be reactivated in the adult brain by environmental manipulations or by pharmacotherapy. These studies open up a tantalizing possibility that targeted pharmacological treatments in combination with regimes of training or rehabilitation might alleviate or reverse the symptoms of neurodevelopmental disorders even after the end of critical developmental periods. Even though translation from animal experimentation to clinical practice is challenging, these results suggest a rational basis for treatment of neurodevelopmental disorders in adulthood.

AB - Brain development in neurodevelopmental disorders has been considered to comprise a sequence of critical periods, and abnormalities occurring during early development have been considered irreversible in adulthood. However, findings in mouse models of neurodevelopmental disorders, including fragile X, Rett syndrome, Down syndrome, and neurofibromatosis type I suggest that it is possible to reverse certain molecular, electrophysiological, and behavioral deficits associated with these disorders in adults by genetic or pharmacological manipulations. Furthermore, recent studies have suggested that critical period-like plasticity can be reactivated in the adult brain by environmental manipulations or by pharmacotherapy. These studies open up a tantalizing possibility that targeted pharmacological treatments in combination with regimes of training or rehabilitation might alleviate or reverse the symptoms of neurodevelopmental disorders even after the end of critical developmental periods. Even though translation from animal experimentation to clinical practice is challenging, these results suggest a rational basis for treatment of neurodevelopmental disorders in adulthood.

UR - http://www.scopus.com/inward/record.url?scp=84867280540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867280540&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3287-12.2012

DO - 10.1523/JNEUROSCI.3287-12.2012

M3 - Article

C2 - 23055475

AN - SCOPUS:84867280540

VL - 32

SP - 14074

EP - 14079

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 41

ER -